Envista (NVST) — insider trading
Health Care · NYSE
Envista (NVST) has 32 reported SEC Form 4 insider transactions in our data, including 1 open-market sale among the most recent 32 (latest 2026-08-25).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-08-25 | Nilsson Stefan | Officer (President, Nobel Biocare) | Shares withheld for taxes / exercise cost | 804 | $27.47 | $22.1K | Form 4 |
| 2026-08-25 | Hammes Eric D. | Officer (Chief Financial Officer) | Shares withheld for taxes / exercise cost | 10,885 | $27.47 | $299.0K | Form 4 |
| 2026-08-25 | Befidi Robert | Officer (President, Diagnostics) | Shares withheld for taxes / exercise cost | 5,147 | $27.47 | $141.4K | Form 4 |
| 2026-08-25 | Acurio Veronica | Officer (President, Orthodontics) | Shares withheld for taxes / exercise cost | 7,710 | $27.47 | $211.8K | Form 4 |
| 2026-08-20 | Reis Mischa | Officer (SVP, Strategy & Bus. Dev.) | Open-market sale | 8,000 | $27.50 | $220.0K | Form 4 |
| 2026-08-18 | Hammes Eric D. | Officer (Chief Financial Officer) | Grant / award / vesting (derivative) | 47,970 | — | $0 | Form 4 |
| 2026-08-18 | Keel Paul A | Director, Officer (Chief Executive Officer) | Grant / award / vesting (derivative) | 159,900 | — | $0 | Form 4 |
| 2026-08-18 | Keel Paul A | Director, Officer (Chief Executive Officer) | Grant / award / vesting | 179,730 | — | $0 | Form 4 |
| 2026-05-25 | Keel Paul A | Director, Officer (Chief Executive Officer) | Shares withheld for taxes / exercise cost | 12,811 | $23.43 | $300.2K | Form 4 |
| 2026-05-19 | Huennekens R Scott | Director | Grant / award / vesting | 12,585 | — | $0 | Form 4 |
| 2026-05-19 | Raskas Daniel | Director | Grant / award / vesting | 9,330 | — | $0 | Form 4 |
| 2026-05-19 | Pierce James Andrew | Director | Grant / award / vesting | 9,330 | — | $0 | Form 4 |
| 2026-05-19 | GALLAHUE KIERAN | Director | Grant / award / vesting | 9,330 | — | $0 | Form 4 |
| 2026-05-19 | Jain Vivek | Director | Grant / award / vesting | 9,330 | — | $0 | Form 4 |
| 2026-05-19 | TSINGOS CHRISTINE A | Director | Grant / award / vesting | 9,330 | — | $0 | Form 4 |
| 2026-05-19 | Carruthers Wendy | Director | Grant / award / vesting | 9,330 | — | $0 | Form 4 |
| 2026-02-25 | Reis Mischa | Officer (SVP, Strategy & Bus. Dev.) | Grant / award / vesting (derivative) | 14,020 | — | $0 | Form 4 |
| 2026-02-25 | Reis Mischa | Officer (SVP, Strategy & Bus. Dev.) | Grant / award / vesting (derivative) | 10,770 | — | $0 | Form 4 |
| 2026-02-25 | Reis Mischa | Officer (SVP, Strategy & Bus. Dev.) | Grant / award / vesting | 5,915 | — | $0 | Form 4 |
| 2026-02-25 | Reis Mischa | Officer (SVP, Strategy & Bus. Dev.) | Shares withheld for taxes / exercise cost | 2,976 | $29.59 | $88.1K | Form 4 |
| 2026-02-25 | Nilsson Stefan | Officer (President, Nobel Biocare) | Grant / award / vesting (derivative) | 18,020 | — | $0 | Form 4 |
| 2026-02-25 | Nilsson Stefan | Officer (President, Nobel Biocare) | Grant / award / vesting (derivative) | 13,845 | — | $0 | Form 4 |
| 2026-02-25 | Nilsson Stefan | Officer (President, Nobel Biocare) | Grant / award / vesting | 7,605 | — | $0 | Form 4 |
| 2026-02-25 | Nilsson Stefan | Officer (President, Nobel Biocare) | Shares withheld for taxes / exercise cost | 182 | $29.59 | $5.4K | Form 4 |
| 2026-02-25 | Acurio Veronica | Officer (President, Orthodontics) | Grant / award / vesting (derivative) | 18,020 | — | $0 | Form 4 |
| 2026-02-25 | Acurio Veronica | Officer (President, Orthodontics) | Grant / award / vesting (derivative) | 13,845 | — | $0 | Form 4 |
| 2026-02-25 | Acurio Veronica | Officer (President, Orthodontics) | Grant / award / vesting | 7,605 | — | $0 | Form 4 |
| 2026-02-25 | Acurio Veronica | Officer (President, Orthodontics) | Shares withheld for taxes / exercise cost | 1,412 | $29.59 | $41.8K | Form 4 |
| 2026-02-25 | Hammes Eric D. | Officer (Chief Financial Officer) | Grant / award / vesting (derivative) | 38,040 | — | $0 | Form 4 |
| 2026-02-25 | Hammes Eric D. | Officer (Chief Financial Officer) | Grant / award / vesting (derivative) | 29,225 | — | $0 | Form 4 |
| 2026-02-25 | Hammes Eric D. | Officer (Chief Financial Officer) | Grant / award / vesting | 16,055 | — | $0 | Form 4 |
| 2026-02-25 | Hammes Eric D. | Officer (Chief Financial Officer) | Shares withheld for taxes / exercise cost | 2,045 | $29.59 | $60.5K | Form 4 |
Ask the chat about NVST's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: Envista (NVST).
Last updated 2026-08-25 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.